TownSquare Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,124
| Closed | -$290K | – | 1737 |
|
|
2024
Q4 | $290K | Buy |
+2,124
| New | +$290K | ﹤0.01% | 1268 |
|
|
2023
Q2 | – | Sell |
-22,874
| Closed | -$2.32M | – | 1098 |
|
|
2023
Q1 | $2.32M | Sell |
22,874
-935
| -4% | -$94.6K | 0.05% | 300 |
|
|
2022
Q4 | $2.84M | Sell |
23,809
-2,679
| -10% | -$320K | 0.07% | 245 |
|
|
2022
Q3 | $2.81M | Sell |
26,488
-593
| -2% | -$63K | 0.08% | 214 |
|
|
2022
Q2 | $2.64M | Buy |
27,081
+2,378
| +10% | +$232K | 0.07% | 223 |
|
|
2022
Q1 | $2.32M | Buy |
24,703
+7,655
| +45% | +$718K | 0.06% | 258 |
|
|
2021
Q4 | $1.45M | Sell |
17,048
-863
| -5% | -$73.5K | 0.04% | 313 |
|
|
2021
Q3 | $1.72M | Buy |
17,911
+2,836
| +19% | +$272K | 0.05% | 280 |
|
|
2021
Q2 | $1.47M | Buy |
15,075
+3,748
| +33% | +$365K | 0.05% | 279 |
|
|
2021
Q1 | $1.1M | Buy |
11,327
+1,326
| +13% | +$129K | 0.04% | 284 |
|
|
2020
Q4 | $958K | Buy |
10,001
+4,262
| +74% | +$408K | 0.04% | 298 |
|
|
2020
Q3 | $557K | Buy |
+5,739
| New | +$557K | 0.03% | 292 |
|